Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
Clinical trial NCT02697734 · COMPLETED
Trial details
- NCT number
- NCT02697734
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-03
- Primary completion
- 2019-06-19
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.